NCT02173717View on ClinicalTrials.gov

Relative Bioavailability of Single Doses of Dabigatran Etexilate in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

July 31, 2009

Conditions
Healthy
Interventions
DRUG

Dabigatran etexilate

150 mg Dabigatran etexilate

DRUG

Rifampicin

600 mg Rifampicin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02173717 - Relative Bioavailability of Single Doses of Dabigatran Etexilate in Healthy Volunteers | Biotech Hunter | Biotech Hunter